Russell Investments Group’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.8K | Sell |
1,211
-1,381
| -53% | -$40.8K | ﹤0.01% | 3059 |
|
|
2025
Q1 | $77.4K | Sell |
2,592
-11,057
| -81% | -$330K | ﹤0.01% | 2810 |
|
|
2024
Q4 | $391K | Sell |
13,649
-6,223
| -31% | -$178K | ﹤0.01% | 2358 |
|
|
2024
Q3 | $768K | Buy |
19,872
+6,276
| +46% | +$243K | ﹤0.01% | 2130 |
|
|
2024
Q2 | $438K | Sell |
13,596
-19,488
| -59% | -$628K | ﹤0.01% | 2245 |
|
|
2024
Q1 | $1.28M | Buy |
33,084
+1,011
| +3% | +$39.2K | ﹤0.01% | 1877 |
|
|
2023
Q4 | $987K | Buy |
32,073
+6,796
| +27% | +$209K | ﹤0.01% | 1974 |
|
|
2023
Q3 | $565K | Buy |
25,277
+6,784
| +37% | +$152K | ﹤0.01% | 2186 |
|
|
2023
Q2 | $397K | Sell |
18,493
-87,503
| -83% | -$1.88M | ﹤0.01% | 2293 |
|
|
2023
Q1 | $2.54M | Buy |
105,996
+79,622
| +302% | +$1.91M | 0.01% | 1433 |
|
|
2022
Q4 | $612K | Buy |
26,374
+16,966
| +180% | +$394K | ﹤0.01% | 2203 |
|
|
2022
Q3 | $150K | Sell |
9,408
-88,968
| -90% | -$1.42M | ﹤0.01% | 2602 |
|
|
2022
Q2 | $1.74M | Sell |
98,376
-10,427
| -10% | -$185K | ﹤0.01% | 1669 |
|
|
2022
Q1 | $2.21M | Buy |
+108,803
| New | +$2.21M | ﹤0.01% | 1591 |
|
|
2020
Q2 | – | Sell |
-80,178
| Closed | -$1.32M | – | 3137 |
|
|
2020
Q1 | $1.32M | Buy |
+80,178
| New | +$1.32M | ﹤0.01% | 1704 |
|
|
2019
Q2 | – | Sell |
-4,253
| Closed | -$67K | – | 2873 |
|
|
2019
Q1 | $67K | Buy |
+4,253
| New | +$67K | ﹤0.01% | 2776 |
|
|
2018
Q3 | – | Sell |
-155,929
| Closed | -$3.72M | – | 2956 |
|
|
2018
Q2 | $3.72M | Sell |
155,929
-3,984
| -2% | -$95.1K | 0.01% | 1426 |
|
|
2018
Q1 | $4.09M | Buy |
+159,913
| New | +$4.09M | 0.01% | 1469 |
|